![Nikhil Lalwani](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Nikhil Lalwani
Vorstandsvorsitzender bei
ANI PHARMACEUTICALS, INC.
Vermögen: 29 Mio $ am 30.06.2026
Profil
Nikhil Lalwani is President, Chief Executive Officer & Director at ANI Pharmaceuticals, Inc. since 2020.
Formerly, Chief Executive Officer-India RX Business at Cipla Ltd. in 2020.
Chief Executive Officer at InvaGen Pharmaceuticals, Inc. from 2016 to 2020.
Chief Executive Officer at Cipla USA, Inc. from 2016 to 2020.
Associate Partner at McKinsey & Co., Inc. Education includes undergraduate studies at Georgia Institute of Technology and both undergraduate and MBA degrees from The Wharton School of the University of Pennsylvania.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 11.05.2026 | 349.889 ( 1,54 % ) | 29 Mio $ | 30.06.2026 |
Aktive Positionen von Nikhil Lalwani
| Unternehmen | Position | Beginn |
|---|---|---|
| ANI PHARMACEUTICALS, INC. | Vorstandsvorsitzender | 08.09.2020 |
Ehemalige bekannte Positionen von Nikhil Lalwani
| Unternehmen | Position | Ende |
|---|---|---|
| CIPLA LIMITED | Corporate Officer/Principal | 01.08.2020 |
InvaGen Pharmaceuticals, Inc.
 InvaGen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes generic prescription medicines | Vorstandsvorsitzender | 01.04.2020 |
Cipla USA, Inc.
 Cipla USA, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Vorstandsvorsitzender | 01.04.2020 |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Corporate Officer/Principal | - |
Ausbildung von Nikhil Lalwani
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
22
Beziehungen ersten Grades
7
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
ANI Pharmaceuticals, Inc.
 ANI Pharmaceuticals, Inc. BiotechnologyHealth Technology Engages in the developing, manufacturing and marketing of generic pharmaceutical products | Health Technology |
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Commercial Services |
Cipla Ltd.
 Cipla Ltd. Pharmaceuticals: OtherHealth Technology Manufactures pharmaceutical products | Health Technology |
Georgia Institute of Technology
 Georgia Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
InvaGen Pharmaceuticals, Inc.
InvaGen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes generic prescription medicines | Health Technology |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cipla USA, Inc.
Cipla USA, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
